Literature DB >> 9703530

Hormone replacement therapy.

E Barrett-Connor1.   

Abstract

Mesh：

Year:  1998        PMID： 9703530      PMCID： PMC1113713          DOI： 10.1136/bmj.317.7156.457

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  36 in total

1.  Quality of life after the menopause: influence of hormonal replacement therapy.

Authors:  M A Limouzin-Lamothe; N Mairon; C R Joyce; M Le Gal
Journal:  Am J Obstet Gynecol       Date:  1994-02       Impact factor: 8.661

2.  Increased risk of cholecystectomy in users of supplemental estrogen.

Authors:  D B Petitti; S Sidney; J A Perlman
Journal:  Gastroenterology       Date:  1988-01       Impact factor: 22.682

3.  Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium.

Authors:  B Ettinger; H K Genant; C E Cann
Journal:  Ann Intern Med       Date:  1987-01       Impact factor: 25.391

Review 4.  Estrogen replacement therapy and stroke.

Authors:  A Paganini-Hill
Journal:  Prog Cardiovasc Dis       Date:  1995 Nov-Dec       Impact factor: 8.194

5.  Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased?

Authors:  W F Posthuma; R G Westendorp; J P Vandenbroucke
Journal:  BMJ       Date:  1994-05-14

6.  Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.

Authors: 
Journal:  JAMA       Date:  1995-01-18       Impact factor: 56.272

7.  Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study.

Authors:  N F Boyd; J W Byng; R A Jong; E K Fishell; L E Little; A B Miller; G A Lockwood; D L Tritchler; M J Yaffe
Journal:  J Natl Cancer Inst       Date:  1995-05-03       Impact factor: 13.506

8.  Estrogen therapy in the management of urinary incontinence in postmenopausal women: a meta-analysis. First report of the Hormones and Urogenital Therapy Committee.

Authors:  J A Fantl; L Cardozo; D K McClish
Journal:  Obstet Gynecol       Date:  1994-01       Impact factor: 7.661

9.  Postmenopausal hormone use and risk of large-bowel cancer.

Authors:  P A Newcomb; B E Storer
Journal:  J Natl Cancer Inst       Date:  1995-07-19       Impact factor: 13.506

10.  Hormone replacement therapy and endometrial cancer risk: a meta-analysis.

Authors:  D Grady; T Gebretsadik; K Kerlikowske; V Ernster; D Petitti
Journal:  Obstet Gynecol       Date:  1995-02       Impact factor: 7.661
View more
  14 in total

1.  Ethnic differences in use of hormone replacement therapy: community based survey.

Authors:  T J Harris; D G Cook; P D Wicks; F P Cappuccio
Journal:  BMJ       Date:  1999-09-04

Review 2.  "Extracts from "Clinical evidence": Menopausal symptoms.

Authors:  J Rymer; E P Morris
Journal:  BMJ       Date:  2000-12-16

Review 3.  Optimisation of treatment by applying programmable rate-controlled drug delivery technology.

Authors:  Yie W Chien; Senshang Lin
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

4.  [Should the menopause be treated?].

Authors:  E Bailón
Journal:  Aten Primaria       Date:  2004-03-15       Impact factor: 1.137

5.  The pharmacoeconomics of hormone replacement therapy.

Authors:  D J Torgerson; D M Reid
Journal:  Pharmacoeconomics       Date:  1999-07       Impact factor: 4.981

6.  Socioeconomic position and hormone replacement therapy use: explaining the discrepancy in evidence from observational and randomized controlled trials.

Authors:  Debbie A Lawlor; George Davey Smith; Shah Ebrahim
Journal:  Am J Public Health       Date:  2004-12       Impact factor: 9.308

Review 7.  Preventing fractures in postmenopausal women with osteoporosis. A review of recent controlled trials of antiresorptive agents.

Authors:  M Hochberg
Journal:  Drugs Aging       Date:  2000-10       Impact factor: 3.923

8.  Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks?

Authors:  Agnès Fournier; Sylvie Mesrine; Marie-Christine Boutron-Ruault; Françoise Clavel-Chapelon
Journal:  J Clin Oncol       Date:  2009-09-14       Impact factor: 44.544

9.  A case-control study on the effect of hormone replacement therapy on ischaemic heart disease.

Authors:  Julia Hippisley-Cox; Mike Pringle; Nicola Crown; Carol Coupland
Journal:  Br J Gen Pract       Date:  2003-03       Impact factor: 5.386

10.  New thoughts about estrogen therapy from the Women's Health Initiative.

Authors:  Marcia Gene Ko
Journal:  Curr Osteoporos Rep       Date:  2008-09       Impact factor: 5.096
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.